课题基金 / 基金详情

Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia

Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia
阐明软骨内骨化的分子机制,针对骨骼发育不良的新治疗策略
批准号:
17590959
负责人:
YASODA Akihiro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

YASODA Akihiro的其他基金

相似基金

相关文献

中文摘要
翻译
利钠肽家族由ANP、BNP和CNP三种内源性配体及其膜上的鸟苷酸环化酶受体GC-A和GC-B组成。结果表明,CNP-GC-B系统对软骨内骨生长有很强的刺激作用,激活CNP-GC-B系统可显著改善FGFR3激活的软骨再生模型小鼠软骨内骨生长障碍。至于机制,CNP/GC-B/cGMP通过抑制成纤维细胞生长因子信号的MAPK通路的激活来恢复减少的软骨基质合成。在本项目中,我们进一步研究了CNP-GC-B系统和成纤维细胞生长因子系统之间的细胞内信号相互作用。首先,我们证明了成纤维细胞生长因子系统同时刺激MAPK和STAT1通路,而CNP-GC-B系统不干扰STAT1通路。我们还发现,成纤维细胞生长因子信号刺激PI3/PKB通路,而CNP-GC-B系统干扰PI3/PKB通路,而PI3/PKB系统在肝素的作用下受到抑制。另一方面,激活成纤维细胞生长因子途径可剂量依赖性地减少CNP-GC-B系统第二信使cGMP的产生。这些结果揭示了软骨中CNP-GC-B系统和成纤维细胞生长因子系统的相互调节。接下来,我们利用胎鼠胫骨器官培养系统研究了软骨局部钠尿肽清除系统。利钠肽清除受体选择性激动剂C-ANF(4-23)呈剂量依赖性延长培养的胎儿胫骨,因此,我们认为局部利钠肽清除系统是软骨中CNP-GC-B系统的调节之一。
英文摘要
Natriuretic peptide family consists of three endogenous ligands, ANP, BNP and CNP, and their membranous guanylyl cyclase receptors, GC-A and GC-B. We have shown that CNP-GC-B system is a strong stimulator of endochondral bone growth and that disturbed endochondral bone growth in mice model of achondroplastic with an activated FGFR3 in cartilage is greatly improved by activation of CNP-GC-B system. As for the mechanism, CNP/GC-B/cGMP restores the decreased cartilaginous matrix synthesis by inhibiting activation of MAPK pathway of FGF signaling.In this project, further we investigated the intracellular signaling interaction between CNP-GC-B system and FGF system in cartilage. First we showed that FGF system stimulates both MAPK and STAT1 pathway and that CNP-GC-B system does not interfere to STAT1 pathway. We also showed that FGF signaling stimulates PI3/PKB pathway to which CNP-GC-B system interferes, and that PI3/PKB system is suppressed under the condition with heparin. On the other hand, activation of FGF pathway decreased the production of cGMP, the second messenger of CNP-GC-B system, dose-dependently. These results exhibit the reciprocal regulation of CNP-GC-B system and FGF system in cartilage.Next we investigated local natriuretic peptide clearance system in cartilage by using fetal mice tibial organ culture system. Selective agonist for natriuretic peptide clearance receptor, C-ANF (4-23), elongated cultured fetal tibiae dose-dependently, and accordingly, we concluded that local natriuretic peptide clearance system works as one of the regulator of CNP-GC-B system in cartilage.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Expression of the aderenomedullin gene in adipose tissue.
脂肪组织中腺髓质素基因的表达。
DOI: --
发表时间: 2005
期刊: Regul Pept 132
影响因子: --
作者: [Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, Itoh H, Nakao K]
通讯作者: Nakao K
DOI: 10.1007/s00198-005-1923-3
发表时间: 2006-01-01
期刊: OSTEOPOROSIS INTERNATIONAL
影响因子: 4
作者: [Natsui, K, Tanaka, K, Nakao, K]
通讯作者: Nakao, K
Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.
抗甲状腺药物抑制甲状腺激素受体介导的转录。
DOI: --
发表时间: 2006
期刊: J Clin Endocrinol Metab. 92・3
影响因子: --
作者: [Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K]
通讯作者: Nakao K
Complementary antagonistic actions between C-Type natriuretic peptide and MAPK pathway through FGFR-3 in ATDC5 Cells.
ATDC5 细胞中 C 型利尿钠肽和 MAPK 通路通过 FGFR-3 的互补拮抗作用。
DOI: --
发表时间: 2005
期刊: Bone 36
影响因子: --
作者: [Ozasa A, Komatsu Y, Yasoda A, Miura M, Nakatsuru Y, Sakuma Y, Arai H, Itoh N, Nakao N]
通讯作者: Nakao N
Translational research for novel therapeutic strategy for skeletal dysplasias
  • 批准号:
    21591176
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    YASODA Akihiro
  • 依托单位:
Translational Research of the CNP/GC-B system for Skeletal dysplasias
  • 批准号:
    19591075
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    YASODA Akihiro
  • 依托单位:
海外基金